Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
FDA reverses course, won't approve leucovorin for autism
FDA reverses course, won't approve leucovorin for autism
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Format:
Artículo Open Access
Published:
Wiley
2026
Subjects:
The Brown University Psychopharmacology Update
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Be the first to leave a comment!
Your Comment
You must be logged in first
Similar Items
2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency
by: Alison Knopf
Published: (2026)
Legal analysis assails FDA's lowering of standards for drug approval
Published: (2026)
FDA approves drug to treat neurologic manifestations of Hunter syndrome
Published: (2026)
Propranolol improved anxiety symptoms in youths with autism
Published: (2024)
Higher autism risk with valproate than topiramate, lamotrigine
Published: (2024)
